Global Retirement Partners’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Buy
+375
New +$11.3K ﹤0.01% 3285
2025
Q4
$3.96K Buy
143
+68
+91% +$1.74K ﹤0.01% 3508
2025
Q3
$1.82K Hold
75
– – ﹤0.01% 3348
2025
Q2
$1.28K Buy
+75
New +$1.31K ﹤0.01% 3383
2024
Q4
$1.86K Hold
75
– – ﹤0.01% 3101
2024
Q3
$1.84K Hold
75
– – ﹤0.01% 2963
2024
Q2
$1.76K Hold
75
– – ﹤0.01% 3009
2024
Q1
$2.48K Hold
75
– – ﹤0.01% 2666
2023
Q4
$1.88K Hold
75
– – ﹤0.01% 2704
2023
Q3
$1.62K Hold
75
– – ﹤0.01% 2613
2023
Q2
$2.4K Hold
75
– – ﹤0.01% 2475
2023
Q1
$2.37K Sell
75
-7
-9% -$276 ﹤0.01% 2438
2022
Q4
$3.21K Buy
82
+7
+9% +$314 ﹤0.01% 2184
2022
Q3
$3K Hold
75
– – ﹤0.01% 2069
2022
Q2
$3K Hold
75
– – ﹤0.01% 2030
2022
Q1
$2K Buy
+75
New +$4.92K ﹤0.01% 2140

Other funds holding BEAM

Global Retirement Partners's BEAM Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 375 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #3285 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in BEAM as recently as Q4 2025.

Global Retirement Partners first reported a position in BEAM in Q1 2022 and has held it in 16 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Global Retirement Partners held 375 shares of Beam Therapeutics worth $12.9K as of Q2 2026.
  • Beam Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3285 holding.
  • Global Retirement Partners first reported a position in Beam Therapeutics in Q1 2022 and has held it in 16 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.